‘Pay-for-performance’ may lead to higher risk for robotic prostate surgery patients
A “perverse disincentive” for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led ...